Tianyin Pharmaceutical, Co., Inc. Announces Cash Dividend to Common Shareholders - Record Date January 29, 2010
Dr. Jiang Guoqing, Tianyin's Chairman and Chief Executive Officer, commented, "We are pleased to pay our quarterly dividend. Our track record of consistent quarterly dividend payments reflects the continued strength of our balance sheet, cash flows, and future growth prospects, as well as our commitment to sharing our profits with our shareholders."
About Tianyin Pharmaceuticals
Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in
Safe Harbor Statement
The Statements which are not historical facts during the presentation are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
For more information, please contact: For the Company: Allen Tang, Ph.D., MBA, Assistant to the CEO in China Tel: +86-158-2122-5642 Email: [email protected] Investors: Mr. Matthew Hayden, HC International Tel: +1-561-245-5155 Email: [email protected] Web: http://www.hcinternational.net
SOURCE Tianyin Pharmaceutical Co., Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article